Literature DB >> 20357729

Women gynecologists' attitude toward their own health.

Alina Weissmann-Brenner1, Baruch Brenner, Jaqueline Sulkes, Boris Kaplan.   

Abstract

BACKGROUND: Following the publication of the results of Women's Health Initiative in 2002 there have been gross changes in the attitude of women and physicians towards the risks and benefits of hormone replacement therapy (HRT). We evaluated the attitude of women gynecologist towards their own health, including adherence to recommended screening tests and self usage and prescription of hormone replacement therapy. MATERIAL/
METHODS: Questionnaires regarding performance of screening tests, self usage and recommendation of HRT were posted by mail to all Israel's women gynecologists.
RESULTS: Ninety questionnaires were eligible for analysis (43.2% response rate). Average age was 48+/-7.7 years. Only 7/90 (7.8%) gynecologists smoke regularly and average body mass index was 25+/-3.8 kg/m2. Most participants performed at least one screening tests in the past 2 years. The median interval from the last self breast exam, mammography, gynecologisy exam, Papanicolaou test, colonoscopy and bone density test was 0.2, 1.82, 1.79, 1.95, 3.27 and 1.41 years, respectively. Most of them (68.3%) did not routinely recommend HRT to their patients. The duration of self HRT usage ranged between 1-20 years (average 5.1+/-3.4 years). Most gynecologists (87.7%) recommended continuous estrogen and progesterone for women with their uterus in place.
CONCLUSIONS: The health profile of Israeli women gynecologists is chracterized by a high performance of screening tests for cancer and low rate of smoking. Our study also demonstrates that the impact of the results of the WHI trial is still well manifested and most Israeli women gynecologists do not routinely recommend HRT to postmenopausal women.

Entities:  

Mesh:

Year:  2010        PMID: 20357729

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  4 in total

1.  Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008.

Authors:  Jung-Nien Lai; Chien-Tung Wu; Pau-Chung Chen; Chiun-Sheng Huang; Song-Nan Chow; Jung-Der Wang
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

2.  Concurrent Use in Taiwan of Chinese Herbal Medicine Therapies among Hormone Users Aged 55 Years to 79 Years and Its Association with Breast Cancer Risk: A Population-Based Study.

Authors:  Yueh-Ting Tsai; Jung-Nien Lai; Chien-Tung Wu; Shun-Ku Lin
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-29       Impact factor: 2.629

3.  Ultrasonographic observation of the breast in early postmenopausal women during therapy with Cimicifuga foetida extract and sequential therapy with estrogen and progestin.

Authors:  Sharen Gaowa; Ai-Jun Sun; Ying Jiang; Fa-Wei He; Ting-Ping Zheng; Ya-Ping Wang
Journal:  Chin Med J (Engl)       Date:  2015-04-20       Impact factor: 2.628

4.  Hormone Replacement Therapy: Lebanese Women's Awareness, Perception, and Acceptance.

Authors:  A Anastasia Salame; Mohammad J Jaffal; Fatin Khalifeh; Dalia Khalife; Ghina Ghazeeri
Journal:  Obstet Gynecol Int       Date:  2020-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.